Q1 finished yesterday champ, hardly cause for acting like a spoilt brat. Some expressed the same attitude with the OSA results, a week later they were released and were sensational.
It’s pretty easy to a proxy CEO from the comfort of your armchair but you clearly have no idea what’s required to develop a clinical program or run a business of this calibre. If you sat down with Joel for 10 minutes I reckon you’d take back most of what you just stated.
Of course if you’re unhappy you can always sell.
IHL Price at posting:
50.5¢ Sentiment: Buy Disclosure: Held
